http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021503506-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-54 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-54 |
filingDate | 2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2021503506-A |
titleOfInvention | Maleate of (E) -N- (3-cyano-7-ethoxy-4-((4-phenoxyphenyl) amino) quinoline-6-yl) -4- (dimethylamino) but-2-enamide and its thereof. Crystal morphology |
abstract | This application is for (E) -N- {4- [3-chloro-4- (2-pyridinylmethoxy) aniline] -3-cyano-7-ethoxy-6-quinolinyl} -4- (dimethylamino). -2-Maleate of butenamide, its crystalline form, methods for its preparation, pharmaceutical compositions containing it, and its use in the control of disorders. [Selection diagram] None |
priorityDate | 2017-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.